Clinical Trial Update: High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated high-dose dual therapy plus bismuth for Helicobacter pylori infection and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED